Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from AbbVie

Best Retirement Stocks for Income Investors in the Golden Years

The best retirement stocks ideally have attractive dividends that can be sustained. This can lead to steady income and long-term value for retirees.

Kiplinger

Market Rally Wobbles Amid Big Earnings Moves From Microsoft, Meta, Crocs, Cloudflare: Weekly Review

The stock market rally went to "under pressure" amid big earnings moves and revived banking fears, but the major indexes ultimately closed tightly again.

Investors Business Daily

Could Government Drug-Price Negotiations Sound The Death Knell For Biotech Stocks?

Industry analysts warn that a groundbreaking change in how Medicare buys drugs threatens industry growth, profits — and maybe patient care.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

AbbVie's Humira Downfall Is Swift As Biosimilars Hammer Away At Sales

AbbVie stock crumbled Thursday after the first biosimilar to launch in the U.S. hammered away at Humira's legendary sales.

Investors Business Daily

Dow Jones Futures Rise: Meta Soars, Drug Giants Climb, Specialty Chip Plays Dive

Futures: Meta Platforms boomed on earnings, but megacap techs can't hide broad market rally weakness. First Republic dived again.

Investors Business Daily

AbbVie Stock Holds Support and Gives Traders a Buying Opportunity

AbbVie stock has been trading well and investors are looking for a breakout.

The Street

AbbVie Stock Shows Improved Relative Price Strength

AbbVie shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

AbbVie’s Call Action Suggests It Might Just Be a Buy

Barchart.com’s Unusual Options Activity on Wednesday had 18 AbbVie call options in the Top 100. Not everyone believes it’s an excellent time to buy ABBV stock. Yesterday’s options market says otherwise.

Barchart

Reskilling and financial well-being top HR’s talent strategy list amid economic downturn

Fortune 500 HR execs share how they’re recession-proofing their talent strategy. Hint: Financial wellness benefits and reskilling.

Fortune

How Fortune 500 companies are supporting employees amid financial instability

Financial wellness benefits have become popular as employers focus on retention.

Fortune

Federal government to penalize AbbVie over the price of its blockbuster drug Humira

North Chicago-based drugmaker AbbVie must pay back Medicare for raising the price of its blockbuster drug Humira too quickly, the federal government said Wednesday.

Chicago Tribune

AbbVie Stock Shows Rising Relative Strength, Still Has More To Go

A Relative Strength Rating upgrade for AbbVie shows improving technical performance. Will it continue?

Investors Business Daily

AbbVie's Humira: The Downfall Won't Be As 'Draconian' As Initially Expected

AbbVie stock won at least one upgrade Friday after issuing long-awaited guidance for Humira for the first year it faces new competition.

Investors Business Daily

AbbVie Rises As Lagging Profit Outlook Better Than Feared In Humira Battle Year

AbbVie stock inched higher Thursday after the company reported mixed earnings and issued a light profit outlook.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Rallies 250 Points After Jobless Claims; Disney Surges On Earnings

The Dow Jones rallied 250 points Thursday after weekly first-time jobless claims. Disney shares surged on earnings results.

StockNews.com

3 Income Stocks to Buy Now if You're Starving for Cash

The Fed will likely keep raising interest rates to bring inflation down to its desired level. This is expected to keep the stock market and the economy under pressure this year. Amid the uncertainty, investors looking for passive income could add fundamentally strong dividend-paying stocks AbbVie (ABBV), Valero Energy (VLO),…

Investors Business Daily

Top Fund Manager Found A Way To Make Money While Others Lose

Making money in an up market is easy. But showering investors with gains when stocks fall is far more challenging for the best mutual funds.

Investors Business Daily

Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric

Biohaven is taking the same tact that led to a nearly $12 billion Pfizer buyout with the rest of its pipeline — and BHVN stock has soared.

Get all your
news in one place.

100’s of premium titles.
One news app.

WEKU

AbbVie's blockbuster drug Humira finally loses its 20-year, $200 billion monopoly

U.S. doctors can now choose Amjevita instead, the first of several close copies of the popular rheumatoid arthritis drug expected this year. But industry-watchers warn consumer savings may be limited.

The Guardian - UK

Ignore the ‘superpower’ boasts – UK pharma looks superchallenged

NHS crisis, withdrawal of tax credits and exit from EU blamed for fall in UK share of R&D market

StockNews.com

The #1 Pharma Stock to Buy in January 2023

While the stock market and the economy have been subdued by progressive interest-rate increases, AbbVie Inc. (ABBV) has not only reported a robust third quarter but also demonstrated its confidence in its long-term prospects by raising its quarterly dividend. Read on….

Investors Business Daily

AbbVie Briefly Breaks Out After Tapping Immunome In $30 Million Cancer Deal

AbbVie stock briefly broke out Friday after the company signed a $30 million deal with small biotech Immunome in antibody development.

StockNews.com

4 Warren Buffett Stocks to Buy and Never Sell

Legendary investor Warren Buffett’s holding company Berkshire Hathaway has outperformed the broader market over the past year. His investment portfolio has been a guide for several long-term investors for decades. Amid a highly uncertain market and economic backdrop, Warren Buffett holdings Procter & Gamble (PG), AbbVie (ABBV), Biogen (BIIB), and…

Investors Business Daily

Dow Jones Dives On This; Tesla Stock Erases Years Of Gains; These Cathie Wood Buys Plunge

The Dow Jones plunged as recession fears rose. Tesla stock suffered a shocking fall. Some Cathie Wood buys got battered. Apple stock dived.

Investors Business Daily

Medical Stocks Lead List Of New Buys By The Best Mutual Funds

The best mutual funds scooped up shares of MRK, LLY, ABBV and AMGN, while also adding retailers like WING to their holiday lists

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations